Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mazza

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1996
Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patientsM Drouin, W H Yang, B Bertrand, et al.
Blood|January 5, 2013
Genetic evidence of PTPN22 effects on chronic lymphocytic leukemiaScott J Hebbring, Susan L Slager, Narendranath Epperla, et al.
Pulmonology|March 23, 2021
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohortS Koirala, S Borisov, E Danila, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 2021
TB and COVID-19 co-infection: rationale and aims of a global studyN Casco, A L Jorge, D Palmero, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 1, 1996
Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patientsM Drouin, W H Yang, B Bertrand, et al.
Blood|January 5, 2013
Genetic evidence of PTPN22 effects on chronic lymphocytic leukemiaScott J Hebbring, Susan L Slager, Narendranath Epperla, et al.
Pulmonology|March 23, 2021
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohortS Koirala, S Borisov, E Danila, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 1, 2021
TB and COVID-19 co-infection: rationale and aims of a global studyN Casco, A L Jorge, D Palmero, et al.
Pageof 16